India’s Sun Pharma says plant listed under U.S. FDA import alert

The U.S. Food and Drug Administration (FDA) had listed Indian drugmaker Sun Pharmaceutical Industries Ltd’s facility in the western Indian state of Gujarat under an import alert, the company said on Thursday, sending its shares down 3.6%.

admin